MITRA

Mithra Pharmaceuticals (MITRA)

Mithra Pharmaceuticals SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:EU:MITRA

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/04	00:30	GlobeNewswire Inc.	Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process	EU:MITRA	Mithra Pharmaceuticals SA
2024/04/29	14:00	GlobeNewswire Inc.	Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023	EU:MITRA	Mithra Pharmaceuticals SA
2024/04/22	14:00	GlobeNewswire Inc.	Mithra secures court protection measures to advance monetization process	EU:MITRA	Mithra Pharmaceuticals SA
2024/03/08	15:00	GlobeNewswire Inc.	Mithra reports full year 2023 financial results	EU:MITRA	Mithra Pharmaceuticals SA
2024/03/05	15:01	GlobeNewswire Inc.	Mithra announces changes to its executive management	EU:MITRA	Mithra Pharmaceuticals SA
2024/03/05	15:00	GlobeNewswire Inc.	Mithra initiates monetization process, receives bridge loan from existing lenders	EU:MITRA	Mithra Pharmaceuticals SA
2024/02/29	19:42	GlobeNewswire Inc.	DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	EU:MITRA	Mithra Pharmaceuticals SA
2024/02/16	02:23	GlobeNewswire Inc.	Mithra sells shares in Mayne Pharma	EU:MITRA	Mithra Pharmaceuticals SA
2024/02/06	15:00	GlobeNewswire Inc.	Mithra updates on cash position	EU:MITRA	Mithra Pharmaceuticals SA
2024/02/06	15:00	GlobeNewswire Inc.	Mithra updates on cash position	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/22	01:45	GlobeNewswire Inc.	Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/22	01:45	GlobeNewswire Inc.	Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/21	01:45	GlobeNewswire Inc.	Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/21	01:45	GlobeNewswire Inc.	Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/18	15:00	GlobeNewswire Inc.	Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/18	15:00	GlobeNewswire Inc.	Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial	EU:MITRA	Mithra Pharmaceuticals SA
2023/12/04	15:00	GlobeNewswire Inc.	Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China	EU:MITRA	Mithra Pharmaceuticals SA
2023/11/30	15:00	GlobeNewswire Inc.	Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States	EU:MITRA	Mithra Pharmaceuticals SA
2023/11/29	01:45	GlobeNewswire Inc.	Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam	EU:MITRA	Mithra Pharmaceuticals SA
2023/11/07	15:00	GlobeNewswire Inc.	Mithra’s NEXTSTELLIS® granted additional patent in the United States	EU:MITRA	Mithra Pharmaceuticals SA
2023/11/07	15:00	GlobeNewswire Inc.	Mithra’s NEXTSTELLIS® granted additional patent in the United States	EU:MITRA	Mithra Pharmaceuticals SA
2023/11/07	02:52	GlobeNewswire Inc.	Mithra releases invitation to its extraordinary securities holders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/26	14:00	GlobeNewswire Inc.	Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/23	14:00	GlobeNewswire Inc.	Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/23	14:00	GlobeNewswire Inc.	Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/17	14:00	GlobeNewswire Inc.	Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/11	14:15	GlobeNewswire Inc.	Shareholder Letter	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/11	14:00	GlobeNewswire Inc.	Mithra announces update to the agenda of its upcoming special general shareholders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/11	01:00	GlobeNewswire Inc.	Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress	EU:MITRA	Mithra Pharmaceuticals SA
2023/10/05	14:00	GlobeNewswire Inc.	Mithra Provides an Update in the Context of Recent Market Developments	EU:MITRA	Mithra Pharmaceuticals SA